Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana M Brantley

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Seminars in Cell & Developmental Biology|November 2, 2011
Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profilingDana M Brantley-Sieders
Angiogenesis|August 11, 2004
Eph receptor tyrosine kinases in angiogenesis: from development to diseaseDana M Brantley-Sieders, Jin Chen
Cytokine & Growth Factor Reviews|December 26, 2001
The ephrins and Eph receptors in angiogenesisNikki Cheng, Dana M Brantley, Jin Chen
Cancers|August 28, 2025
Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in Murine Models of Non-Small Cell Lung CancerEileen Shiuan, Shan Wang, Dana M Brantley-Sieders
Breast Cancer Research : BCR|January 16, 2009
Eph receptors in breast cancer: roles in tumor promotion and tumor suppressionDavid Vaught, Dana M Brantley-Sieders, Jin Chen
Oncogene|March 9, 2021
Oncogenic functions and therapeutic targeting of EphA2 in cancerKalin Wilson, Eileen Shiuan, Dana M Brantley-Sieders
Molecular Biology of the Cell|March 27, 2009
Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinaseDavid Vaught, Jin Chen, Dana M Brantley-Sieders
Cancer Research|November 3, 2006
Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in miceDana M Brantley-Sieders, Wei Bin Fang, Yoonha Hwang, et al.
Journal of Clinical and Translational Science|January 15, 2026
The impact of Susan G. Komen-funded research on approved drugs for breast cancer treatmentDana M Brantley-Sieders, Lauren Leslie, Kimberly Sabelko, et al.
Oncogene|August 17, 2005
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasisWei Bin Fang, Dana M Brantley-Sieders, Monica A Parker, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Seminars in Cell & Developmental Biology|November 2, 2011
Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profilingDana M Brantley-Sieders
Angiogenesis|August 11, 2004
Eph receptor tyrosine kinases in angiogenesis: from development to diseaseDana M Brantley-Sieders, Jin Chen
Cytokine & Growth Factor Reviews|December 26, 2001
The ephrins and Eph receptors in angiogenesisNikki Cheng, Dana M Brantley, Jin Chen
Cancers|August 28, 2025
Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in Murine Models of Non-Small Cell Lung CancerEileen Shiuan, Shan Wang, Dana M Brantley-Sieders
Breast Cancer Research : BCR|January 16, 2009
Eph receptors in breast cancer: roles in tumor promotion and tumor suppressionDavid Vaught, Dana M Brantley-Sieders, Jin Chen
Oncogene|March 9, 2021
Oncogenic functions and therapeutic targeting of EphA2 in cancerKalin Wilson, Eileen Shiuan, Dana M Brantley-Sieders
Molecular Biology of the Cell|March 27, 2009
Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinaseDavid Vaught, Jin Chen, Dana M Brantley-Sieders
Cancer Research|November 3, 2006
Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in miceDana M Brantley-Sieders, Wei Bin Fang, Yoonha Hwang, et al.
Journal of Clinical and Translational Science|January 15, 2026
The impact of Susan G. Komen-funded research on approved drugs for breast cancer treatmentDana M Brantley-Sieders, Lauren Leslie, Kimberly Sabelko, et al.
Oncogene|August 17, 2005
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasisWei Bin Fang, Dana M Brantley-Sieders, Monica A Parker, et al.
Pageof 5